L1 Capital Pty LTD Concert Pharmaceuticals, Inc. Transaction History

L1 Capital Pty LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$4.86 - $13.07 $5.58 Million - $15 Million	-1,149,120 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.48 - $12.84 $938,482 - $1.27 Million	98,996 Added 9.43%	1,149,120 $14.6 Million
Q3 2020 Nov 13, 2020	BUY	$8.67 - $10.82 $710,298 - $886,439	81,926 Added 8.46%	1,050,124 $10.3 Million
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $7.55 Million - $11.2 Million	968,198 New	968,198 $9.63 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of L1 Capital Pty LTD, based on Form 13F filings with the SEC.

Stay updated on L1 Capital Pty LTD with notifications on news.